Can-Fite BioPharma CANF
NYSE CANF
$1.89 0.00 (-0.02%)
As of: Oct 21, 2026 · 3:21 PM EDT

Can-Fite BioPharma (CANF) Capital Expenditures (2012 - 2013)

Updated

Can-Fite BioPharma (CANF) recorded Capital Expenditures of -$2,000 in FY2025, compared with -$5,000 in FY2024.

Analysis

Can-Fite BioPharma (CANF) Capital Expenditures (2012 - 2013) Analysis & Trends

Starting with FY2015, Can-Fite BioPharma's Capital Expenditures history includes 11 years.

  • Per Business Quant data, CANF's Capital Expenditures was -$5,000 in FY2024, -$2,000 in FY2023, -$9,000 in FY2022 and -$11,000 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 2.93 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 1.32 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 322.00 Mn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 893.00 Mn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 321.00 Mn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 1.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 513.00 Mn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 140.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 533.00 Mn
10 Can-Fite BioPharma 1.56 Mn -18.15 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2013 -7,176.51
Jun 30, 2012 -3,411.01
API Access

Can-Fite BioPharma Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=CANF&period=max&api_key=YOUR_API_KEY